Literature DB >> 3375348

Lambdoid synostosis: surgical considerations.

J A Persing1, J B Delashaw, J A Jane, M T Edgerton.   

Abstract

Premature closure of the lambdoid suture may result in abnormalities in skull shape not only in the parieto-occipital region, but also in the frontal region and at the vertex of the skull. Although most of these abnormalities are mild, some constitute significant abnormalities in shape and therefore require specific surgical correction. In this report, we describe our approach from five patients we have treated and followed for 6 to 24 months with abnormalities characteristic of unilateral and bilateral lambdoid synostosis. We describe our approach to the simultaneous correction of frontal, occipital, and abnormal vertical height skeletal abnormalities in one operative procedure. To date, no negative neurologic sequelae have resulted from this operative approach, but significant improvement in skull form has been appreciated.

Entities:  

Mesh:

Year:  1988        PMID: 3375348     DOI: 10.1097/00006534-198806000-00006

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

1.  Posterior skull surgery in craniosynostosis.

Authors:  S Sgouros; J H Goldin; A D Hockley; M J Wake
Journal:  Childs Nerv Syst       Date:  1996-11       Impact factor: 1.475

2.  T-bone plastique for treatment of brachy-turricephaly.

Authors:  E Donauer; M Bernardy; D Neuenfeldt
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

3.  Clinical and imaging findings in children with non-syndromic lambdoid synostosis.

Authors:  K Haas-Lude; M Wolff; B Will; B Bender; M Krimmel
Journal:  Eur J Pediatr       Date:  2013-10-27       Impact factor: 3.183

Review 4.  Posterior Cranial Vault Distraction Osteogenesis with Barrel Stave Osteotomy in the Treatment of Craniosynostosis.

Authors:  Yuzo Komuro; Azusa Shimizu; Kazuaki Shimoji; Masakazu Miyajima; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-07-28       Impact factor: 1.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.